Genzyme Corporation (Nasdaq: GENZ) today announced that the European Commission has approved Renvela® (sevelamer carbonate) for the control of serum phosphorus in patients with chronic kidney disease ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme Corporation (Nasdaq: GENZ) today announced that the European Medicines Agency's Committee for Human Medicinal Products (CHMP) has adopted a positive opinion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results